Eisai Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other
pharmaceutical manufacturers in North America:
Daiichi Sankyo Company Limited
sales of $9.06 billion
of which 93%
was Prescription drugs),
Prestige Consumer Healthcare Inc
of which 89%
was North Ameriican OTC Healthcare), and
Canopy Growth Corp
based in CANADA
(398.77 million Canadian Dollars [US$291.93 million]
of which 52%
was Recreational cannabis revenue).
Eisai Company Limited reported sales of $6.42 billion
March of 2020.
increase of 10.9%
versus 2019, when the company's sales were $5.79 billion.
This was the fourth straight year of sales growth at Eisai Company Limited.
Sales of Other Business saw an increase
that was more than double the company's growth rate: sales were up
53.3% in 2020, from
$712.60 million to $1.09 billion.